|
LOC285074 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.640430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.642000E-01 |
| Normal-vs-Stage2 |
2.451000E-01 |
| Normal-vs-Stage3 |
8.237600E-02 |
| Normal-vs-Stage4 |
1.469640E-01 |
| Stage1-vs-Stage2 |
4.303000E-01 |
| Stage1-vs-Stage3 |
1.618990E-01 |
| Stage1-vs-Stage4 |
2.431800E-01 |
| Stage2-vs-Stage3 |
8.274400E-01 |
| Stage2-vs-Stage4 |
7.903000E-01 |
| Stage3-vs-Stage4 |
9.209000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.626630E-01 |
| Normal-vs-AfricanAmerican |
5.952000E-01 |
| Normal-vs-Asian |
1.962800E-01 |
| Caucasian-vs-AfricanAmerican |
8.722600E-01 |
| Caucasian-vs-Asian |
7.842200E-01 |
| AfricanAmerican-vs-Asian |
7.493200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.330400E-01 |
| Normal-vs-Female |
1.016430E-01 |
| Male-vs-Female |
2.272000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.425000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.354000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.130100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.763880E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.883800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.418390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.218000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.193600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.988390E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.468000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.415530E-03 |
| Classical-VS-Follicular |
6.497400E-01 |
| Classical-VS-Other |
7.387600E-01 |
| Classical-VS-Normal |
4.666800E-01 |
| Tall-VS-Follicular |
2.862200E-02 |
| Tall-VS-Other |
5.863500E-02 |
| Tall-VS-Normal |
1.841360E-03 |
| Follicular-VS-Other |
6.752600E-01 |
| Follicular-VS-Normal |
3.609800E-01 |
| Other-VS-Normal |
9.203400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.876020E-01 |
| Normal-vs-N1 |
2.604000E-01 |
| N0-vs-N1 |
8.865400E-01 |
|
|
